Microsoft Equity Method Investments increased by 84.9% to $21.20B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 36.1%, from $15.58B to $21.20B. Over 4 years (FY 2021 to FY 2025), Equity Method Investments shows an upward trend with a 26.7% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.98B | $6.39B | $6.99B | $6.91B | $6.89B | $6.84B | $7.10B | $9.42B | $9.88B | $11.42B | $13.37B | $14.81B | $14.60B | $15.78B | $15.58B | $16.04B | $15.41B | $11.47B | $21.20B |
| QoQ Change | — | +6.8% | +9.4% | -1.2% | -0.2% | -0.8% | +3.8% | +32.7% | +4.9% | +15.6% | +17.0% | +10.8% | -1.4% | +8.1% | -1.2% | +2.9% | -3.9% | -25.6% | +84.9% |
| YoY Change | — | — | — | — | +15.2% | +7.0% | +1.5% | +36.3% | +43.4% | +67.0% | +88.3% | +57.3% | +47.8% | +38.1% | +16.6% | +8.3% | +5.5% | -27.3% | +36.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.